General Atlantic Portfolio
Our portfolio companies are already on a strong growth trajectory — our goal is to enhance it. We have a solid track record of delivering strategic, practical and impactful support to our portfolio companies.
Ultima Genomics ×
Ultima Genomics focuses on developing next-generation genome sequencing technology for the high-volume research and clinical markets.